Cancer vaccines have been shown clinically to drive tumor-reactive cell activation,
proliferation, and effector function. Unfortunately, tumor eradication by treatment with cancer …

Therapeutic vaccines are a promising alternative for active immunotherapy for different types
of cancers. Therapeutic cancer vaccines aim to prevent immune system responses that are …

There are strong biologic and preclinical rationales for the development of therapeutic
cancer vaccines; however, the clinical translation of this treatment strategy has been …

Therapeutic vaccines represent a viable option for active immunotherapy of cancers that aim
to treat late stage disease by using a patient's own immune system. The promising results …

The advent of cancer immunotherapy has revolutionized the field of cancer treatment and
offers cancer patients new hope. Although this therapy has proved highly successful for …

Background: Cancer vaccines are a unique approach to cancer therapy. They exert an
antitumor effect by engaging the host immune response, and have great potential for …

In this editorial, we highlight articles published in this Special Issue of Vaccines on “Cancer
Vaccines and Immunotherapy for Tumor Prevention and Treatment”, recent developments in …

Cancer vaccines are at the forefront of novel, targeted approaches to cancer treatment. Low
toxicity, the potential for circumventing drug cross-resistance, and the potential for …

Therapeutic cancer vaccines represent an emerging therapeutic modality that may play a
more prominent role in cancer treatment in the future. Therapeutic cancer vaccines are …

Immunotherapy has become a standard approach for cancer management, through the use
of cytokines (eg: interleukin-2) and monoclonal antibodies. Cancer vaccines hold promise …